CB-10-YX20_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, 2-(2-Phenylethenyl)-4-(pyridin-3-ylmethylidene)-4,5-dihydro-1,3-oxazol-5-one, DAPK1/3 inhibitor targeting DAPK1 (Novartis, 2360773)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/2360773
Similar Terms
Downloads & Tools

Genes

10 genes differentially expressed following the CB-10-YX20_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
NDUFS7 NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) 0.853084
SH2D4B SH2 domain containing 4B 0.757677
THOC6 THO complex 6 0.638462
TBCB tubulin folding cofactor B 0.437742
RPL18A ribosomal protein L18a 0.327149
OAZ1 ornithine decarboxylase antizyme 1 0.327149
DKK3 dickkopf WNT signaling pathway inhibitor 3 0.317728
RPS14 ribosomal protein S14 0.317728
LGALS1 lectin, galactoside-binding, soluble, 1 0.225411
CSNK2B casein kinase 2, beta polypeptide 0.216361